comparemela.com

Latest Breaking News On - Indaptus therapeutics inc - Page 4 : comparemela.com

Indaptus Therapeutics, Inc (INDP) Tops Q3 EPS by 5c

Indaptus Therapeutics, Inc (INDP) Tops Q3 EPS by 5c
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Indaptus Therapeutics (NASDAQ:INDP) Earns Buy Rating from HC Wainwright

HC Wainwright restated their buy rating on shares of Indaptus Therapeutics (NASDAQ:INDP – Free Report) in a research note issued to investors on Wednesday, Benzinga reports. HC Wainwright currently has a $12.00 target price on the stock. Indaptus Therapeutics Stock Down 18.6 % Indaptus Therapeutics stock opened at $2.71 on Wednesday. The firm has a […]

Indaptus Therapeutics (NASDAQ:INDP) Receives Buy Rating from HC Wainwright

Indaptus Therapeutics (NASDAQ:INDP) Receives Buy Rating from HC Wainwright
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Indaptus Therapeutics, Inc (NASDAQ:INDP) Short Interest Update

Indaptus Therapeutics, Inc (NASDAQ:INDP) Short Interest Update
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Indaptus Therapeutics, Inc (NASDAQ:INDP) Short Interest Up 115 2% in August

Indaptus Therapeutics, Inc. (NASDAQ:INDP – Get Free Report) was the target of a significant growth in short interest in the month of August. As of August 15th, there was short interest totalling 46,700 shares, a growth of 115.2% from the July 31st total of 21,700 shares. Approximately 0.8% of the shares of the stock are […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.